Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DCL001161

Drug Information
NameBMS 790052
CompanyBristol-Myers Squibb
IndicationHepatitis C
[ICD9: 070.4, 070.5, 070.70   ICD10: B17.1, B18.2]
Phase II    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Canonical SMILESCC(C)C(C(=O)N1CCCC1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)
Isomeric SMILESCC(C)C(C(=O)N1CCC[C@H]1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)
PubChem Compound IDCID 56843380.
TargetHCV NS5A proteinInhibitor[1]
Ref 12011 Pipeline of Bristol-Myers Squibb. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links


Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543